Targeting KRAS Mutations: A Novel Approach in Advanced NSCLC

Targeting KRAS Mutations: A Novel Approach in Advanced NSCLC

Episodes

Specialty:

All

Year:

All

EP. 1: Current Management of Oncogene-Driven NSCLC

ByPaul Bunn, MD, University of Colorado Cancer Center,Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center,Jonathan Riess, MD, MS, UC Davis Comprehensive Cancer Center

August 3rd 2020

EP. 2: KRAS Mutations in Solid Tumors

ByPaul Bunn, MD, University of Colorado Cancer Center,Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center,Jonathan Riess, MD, MS, UC Davis Comprehensive Cancer Center

August 3rd 2020

EP. 3: Testing for KRAS Mutations in NSCLC

ByPaul Bunn, MD, University of Colorado Cancer Center,Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center,Jonathan Riess, MD, MS, UC Davis Comprehensive Cancer Center

August 3rd 2020

EP. 4: Counseling Patients With NSCLC When KRAS is Detected

ByPaul Bunn, MD, University of Colorado Cancer Center,Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center,Jonathan Riess, MD, MS, UC Davis Comprehensive Cancer Center

August 3rd 2020

EP. 5: Systemic Therapy for KRAS+ Advanced NSCLC

ByPaul Bunn, MD, University of Colorado Cancer Center,Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center,Jonathan Riess, MD, MS, UC Davis Comprehensive Cancer Center

August 3rd 2020

EP. 6: Development of KRAS G12C-Targeted Therapy in NSCLC

ByPaul Bunn, MD, University of Colorado Cancer Center,Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center,Jonathan Riess, MD, MS, UC Davis Comprehensive Cancer Center

August 3rd 2020

EP. 7: KRAS G12C Inhibition in Advanced NSCLC: AMG 510

ByPaul Bunn, MD, University of Colorado Cancer Center,Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center,Jonathan Riess, MD, MS, UC Davis Comprehensive Cancer Center

August 3rd 2020

EP. 8: KRAS G12C Inhibition in Advanced NSCLC: MRTX849

ByPaul Bunn, MD, University of Colorado Cancer Center,Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center,Jonathan Riess, MD, MS, UC Davis Comprehensive Cancer Center

August 3rd 2020

Trending on OncLive

Five Under 5: Top Oncology Videos for the Week of 10/12

CHMP Recommends Approval of Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer

Early-Phase INCA33890 Data Lay the Foundation for Phase 3 Combination Research in MSS CRC

VOLGA, DASL-HiCaP Data Highlight Key Genitourinary Cancer Presentations Arriving at ESMO 2026

The OncFive: Top Oncology Articles for the Week of 10/11